全文获取类型
收费全文 | 5346篇 |
免费 | 343篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 88篇 |
妇产科学 | 89篇 |
基础医学 | 794篇 |
口腔科学 | 42篇 |
临床医学 | 619篇 |
内科学 | 1377篇 |
皮肤病学 | 146篇 |
神经病学 | 512篇 |
特种医学 | 273篇 |
外国民族医学 | 1篇 |
外科学 | 839篇 |
综合类 | 6篇 |
一般理论 | 3篇 |
预防医学 | 208篇 |
眼科学 | 45篇 |
药学 | 324篇 |
中国医学 | 6篇 |
肿瘤学 | 303篇 |
出版年
2024年 | 3篇 |
2023年 | 60篇 |
2022年 | 125篇 |
2021年 | 289篇 |
2020年 | 162篇 |
2019年 | 229篇 |
2018年 | 274篇 |
2017年 | 150篇 |
2016年 | 198篇 |
2015年 | 227篇 |
2014年 | 295篇 |
2013年 | 344篇 |
2012年 | 496篇 |
2011年 | 428篇 |
2010年 | 280篇 |
2009年 | 207篇 |
2008年 | 300篇 |
2007年 | 261篇 |
2006年 | 237篇 |
2005年 | 224篇 |
2004年 | 196篇 |
2003年 | 161篇 |
2002年 | 147篇 |
2001年 | 41篇 |
2000年 | 35篇 |
1999年 | 47篇 |
1998年 | 20篇 |
1997年 | 18篇 |
1996年 | 9篇 |
1995年 | 13篇 |
1994年 | 5篇 |
1993年 | 11篇 |
1992年 | 23篇 |
1991年 | 25篇 |
1990年 | 33篇 |
1989年 | 20篇 |
1988年 | 14篇 |
1987年 | 20篇 |
1986年 | 17篇 |
1985年 | 21篇 |
1984年 | 11篇 |
1983年 | 5篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1979年 | 5篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1970年 | 2篇 |
1890年 | 1篇 |
排序方式: 共有5708条查询结果,搜索用时 15 毫秒
991.
Substrate factors such as surface energy distribution can affect cell functions, such as neuronal differentiation of PC12 cells. However, the surface effects that trigger such cell responses need to be clarified and analyzed. Here we show that the total surface tension is not a critical parameter. Self-assembled monolayers of alkylsiloxanes on glass were used as culture substrates. By changing the nanoscale structure and ordering of the monolayer, we designed surfaces with a range of dispersive (γ(d) ) and nondispersive (γ(nd) ) potentials, but with a similar value for total free-energy (50 ≤ γ(d) + γ(nd) ≤ 55 mN m?1). When seeded on surfaces displaying γ(d) /γ(nd) ≤ 3.7, PC12 cells underwent low level of neuritogenesis. On surfaces exhibiting γ(d) /γ(nd) ≥ 5.4, neurite outgrowth was greatly enhanced and apparent by only 24 h of culture in absence of nerve growth-factor treatment. These data indicate how the spatial distribution of surface potentials may control neuritogenesis, thus providing a new criterion to address nerve regeneration issues on rigid biocompatible surfaces. 相似文献
992.
Héron B Mikaeloff Y Froissart R Caridade G Maire I Caillaud C Levade T Chabrol B Feillet F Ogier H Valayannopoulos V Michelakakis H Zafeiriou D Lavery L Wraith E Danos O Heard JM Tardieu M 《American journal of medical genetics. Part A》2011,155(1):58-68
Sanfilippo syndrome, or mucopolysaccharidosis type III (MPSIII) is a lysosomal storage disease with predominant neurological manifestations in affected children. It is considered heterogeneous with respect to prevalence, clinical presentation, biochemistry (four biochemical forms of the disease referred to as MPSIIIA, B, C, and D are known), and causative mutations. The perspective of therapeutic options emphasizes the need for better knowledge of MPSIII incidence and natural history. We performed parallel retrospective epidemiological studies of patients diagnosed with MSPIII in France (n = 128), UK (n = 126), and Greece (n = 20) from 1990 to 2006. Incidences ranged from 0.68 per 100,000 live‐births in France to 1.21 per 100,000 live‐births in UK. MPSIIIA, which predominates in France and UK, was absent in Greece, where most patients have MPSIIIB. The study confirmed the large allelic heterogeneity of MPSIIIA and MPSIIIB and detected several yet undescribed mutations. Analysis of clinical manifestations at diagnosis and over a 6–7 years follow‐up indicated that almost all patients, whatever the disease subtype, expressed neurological manifestations before the age of 5 years, including language acquisition delay, cognitive delay, and/or abnormal behavior. In contrast to relatively homogeneous early onset manifestations, disease progression showed significant variation depending on subtype and age at diagnosis. Different severities of disease progressions and different allele distribution between France and UK suggested that mutations are not equally deleterious, although genotype–phenotype correlation could not be established. Notwithstanding the rapidity of further clinical deterioration, all MPSIII patients suffer early onset devastating neurological manifestations that deserve early treatment when available. © 2010 Wiley‐Liss, Inc. 相似文献
993.
994.
Chaste P Clement N Botros HG Guillaume JL Konyukh M Pagan C Scheid I Nygren G Anckarsäter H Rastam M Ståhlberg O Gillberg IC Melke J Delorme R Leblond C Toro R Huguet G Fauchereau F Durand C Boudarene L Serrano E Lemière N Launay JM Leboyer M Jockers R Gillberg C Bourgeron T 《Journal of pineal research》2011,51(4):394-399
Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration in melatonin signaling has been reported in a broad range of diseases, but little is known about the genetic variability of this pathway in humans. Here, we sequenced all the genes of the melatonin pathway -AA-NAT, ASMT, MTNR1A, MTNR1B and GPR50 - in 321 individuals from Sweden including 101 patients with attention-deficit/hyperactivity disorder (ADHD) and 220 controls from the general population. We could find several damaging mutations in patients with ADHD, but no significant enrichment compared with the general population. Among these variations, we found a splice site mutation in ASMT (IVS5+2T>C) and one stop mutation in MTNR1A (Y170X) - detected exclusively in patients with ADHD - for which biochemical analyses indicated that they abolish the activity of ASMT and MTNR1A. These genetic and functional results represent the first comprehensive ascertainment of melatonin signaling deficiency in ADHD. 相似文献
995.
Chanoit G Zhou J Lee S McIntosh R Shen X Zvara DA Xu Z 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2011,25(4):299-306
Purpose
We tested if inhibition of phosphodiesterases (PDEs) with IBMX (1-methyl-3-isobutylxanthine) can modulate the mitochondrial permeability transition pore (mPTP) opening by inactivating glycogen synthase kinase 3β (GSK-3β). 相似文献996.
997.
998.
999.
Bodineau L Taveau C Lê Quan Sang HH Osterstock G Queguiner I Moos F Frugière A Llorens-Cortes C 《Endocrinology》2011,152(9):3492-3503
Apelin is a bioactive peptide identified as the endogenous ligand of the human orphan G protein-coupled receptor APJ in 1998. The present data show that apelin modulates the activity of magnocellular and parvocellular oxytocin (OXY) neurons in the lactating rat. A combination of in situ hybridization and immunohistochemistry demonstrated the presence of apelin receptor mRNA in hypothalamic OXY neurons. Double immunofluorescence labeling then revealed the colocalization of apelin with OXY in about 20% of the hypothalamic OXY-positive neurons. Intracerebroventricular apelin administration inhibited the activity of magnocellular and parvocellular OXY neurons, as shown by measuring the c-fos expression in OXY neurons or by direct electrophysiological measurements of the electrical activity of these neurons. This effect was correlated with a decrease in the amount of milk ejected. Thus, apelin inhibits the activity of OXY neurons through a direct action on apelin receptors expressed by these neurons in an autocrine and paracrine manner. In conclusion, these findings highlight the inhibitory role of apelin as an autocrine/paracrine peptide acting on OXY neurons during breastfeeding. 相似文献
1000.